A detailed history of Acuitas Investments, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Acuitas Investments, LLC holds 796,401 shares of CMRX stock, worth $700,832. This represents 0.35% of its overall portfolio holdings.

Number of Shares
796,401
Previous 638,657 24.7%
Holding current value
$700,832
Previous $562,000 31.67%
% of portfolio
0.35%
Previous 0.32%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$0.77 - $1.07 $121,462 - $168,786
157,744 Added 24.7%
796,401 $740,000
Q2 2024

Aug 05, 2024

BUY
$0.87 - $1.05 $2,954 - $3,565
3,396 Added 0.53%
638,657 $562,000
Q1 2024

May 10, 2024

BUY
$0.91 - $1.26 $289,998 - $401,536
318,680 Added 100.66%
635,261 $673,000
Q4 2023

Feb 02, 2024

SELL
$0.9 - $1.06 $127,089 - $149,682
-141,210 Reduced 30.85%
316,581 $303,000
Q3 2023

Oct 27, 2023

SELL
$0.94 - $1.23 $24 - $31
-26 Reduced 0.01%
457,791 $439,000
Q2 2023

Aug 07, 2023

BUY
$1.1 - $1.54 $503,598 - $705,038
457,817 New
457,817 $553,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.